Hydroquinone Research Compound Overview
Hsquin 400 mg hydroquinone is a research-grade dermatological compound manufactured by Johnlee Pharmaceuticals for laboratory investigation of melanogenesis pathways. Hydroquinone functions as a benzene-based phenolic compound that inhibits tyrosinase activity, the rate-limiting enzyme in melanin biosynthesis. Research teams at Stroid UK Shop utilise this compound to examine skin pigmentation mechanisms and depigmentation processes in controlled laboratory settings. The 400 mg formulation provides standardised dosing for reproducible experimental protocols investigating melanocyte biology and pigmentary disorders.
Laboratory Research Applications
Research teams investigate Hsquin for melanogenesis inhibition studies, examining its effects on tyrosinase enzyme kinetics and melanin production pathways. Laboratory protocols evaluate hydroquinone’s impact on melanocyte proliferation, cellular oxidative stress responses, and pigment transfer mechanisms. Studies examine concentration-dependent effects on melanin synthesis, comparing efficacy across different cell culture models. Researchers within our dermatological products collection utilise this compound alongside other depigmenting agents to study synergistic mechanisms. Advanced research protocols investigate hydroquinone’s interaction with antioxidant systems, examining its dual role as both a depigmenting agent and potential source of reactive oxygen species. Comparative studies evaluate hydroquinone effectiveness against alternative melanogenesis inhibitors, establishing concentration thresholds for optimal research outcomes. Research teams also examine formulation stability and degradation pathways, crucial for maintaining compound integrity throughout extended experimental periods. These investigations complement broader research programmes examining skin biology, available through our SARMs research collection and peptides research range for comprehensive molecular studies.
Technical Specifications
| Active Compound | Hydroquinone |
|---|---|
| Concentration | 400 mg per unit |
| Manufacturer | Johnlee Pharmaceuticals |
| CAS Number | 123-31-9 |
| Molecular Formula | C₆H₆O₂ |
| Molecular Weight | 110.11 g/mol |
| Storage Requirements | Room temperature, protect from light |
| Research Applications | Melanogenesis inhibition, tyrosinase studies |
Research Compliance Statement
Hsquin 400 mg hydroquinone is manufactured exclusively for in-vitro laboratory research and analytical testing purposes. This compound is not approved for human consumption, therapeutic use, or any clinical applications. Research teams must maintain appropriate laboratory safety protocols when handling hydroquinone, including proper ventilation and protective equipment due to its potential for causing skin sensitisation in laboratory environments. All experimental protocols should comply with institutional research guidelines and safety regulations. This product is intended solely for qualified researchers conducting legitimate scientific investigations into melanogenesis pathways and dermatological research applications.
